Novel use of fda-approved drugs identified by cluster analysis of behavioral profiles

HIGHLIGHTS

• who: Sara Tucker Edmister from the DepartmentBrown University have published the research: Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles, in the Journal: Scientific Reports Scientific Reports
• what: The authors focused on bromocriptine, nebivolol, and cabozantinib (XL184). This study shows that a wide variety of FDA-approved drugs affect behavior. Instead, the authors aimed to avoid bias by examining a large number of treatment groups and using automated methods for imaging, image analysis, and data processing.
• how: To evaluate such changes in more detail the authors carried out . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.